High DNM2 expression is reported in bladder cancer [46], whereas Chernikova et al. showed that levels of DNM2 could predict chemotherapy outcomes for triple-negative BrCa patients [47]. The gene discussed is DNM2; the disease is urinary bladder carcinoma.